title: Generalized erythroderma and palmoplantar hyperkeratosis in a patient receiving TNF-alpha antagonist therapy.
authors.forename: Karin M
authors.initials: KM
authors.lastname: Dunst-Huemer
authors.forename: Christine
authors.initials: C
authors.lastname: Scheurecker
authors.forename: Josef
authors.initials: J
authors.lastname: Auboeck
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003875:Drug Eruptions / Q000473:pathology*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D014409:Tumor Necrosis Factor-alpha
keywords: TNF-alpha antagonist; adalimumab; adverse skin reaction; erythroderma